choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:

European Patent Office Newsletter
  • USPTO, JPO, and EPO Meet to Discuss Global IP Challenges 31 Oct 2025 00:01 GMT

    … A. Squires met with European Patent Office (EPO) Vice-President Steve Rowan … and Japanese Patent Office (JPO) Commissioner … the Deputy Director General, Patents and Technology Sector for … efficiency and patent quality at the USPTO, EPO, and JPO …

  • Navrogen Granted Patents on Humoral Immuno-Oncology (HIO) Technology and HIO-Refractory NAV-001 Antibody-Drug Conjugate 30 Oct 2025 11:58 GMT

    … has been granted patents by the European Patent Office (EPO) and Japanese Patent Office (JPO) covering … therapeutic product. The EPO has granted the company Patent No. 3857235, which … oncology (HIO) factor immunosuppression. The patent also covers the use for …

  • EPO meets with CEA 28 Oct 2025 15:27 GMT

    The European Patent Office (EPO) recently held an online user … the Unitary Patent. The meeting is part of the EPO’s … with users Steve Rowan, EPO Vice-President Patent Granting Process, opened the … in the EPO User Day 2025 panel session “Why patents matter for …

  • ​​Collaborating for impact: EPO and IP Australia reach new milestones​ 27 Oct 2025 12:27 GMT

    … applicants to designate the EPO as their International … the path towards European patent protection.  ​Further progress … status as a Cooperative Patent Classification (CPC) partner … continue strengthening collaboration in patent classification and to …

  • ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy® (epinephrine nasal spray) 08 Oct 2025 12:00 GMT

    … Division of the European Patent Office (the “EPO”) upheld the validity … , two different ARS Pharma patents, with differing claim scope … following two independent patent challenges in two … patents, provide confidence in our ability to overcome future patent

  • EPO and FICPI strengthen dialogue on AI and co-operation in the patent system 24 Oct 2025 16:40 GMT

    … delegations In October 2025, the European Patent Office (EPO) and the International Federation of … Action Plan 2025, the EPO Observatory on Patents and Technology, and the … expand the reach of European patents beyond Europe.  Leveraging AI, safeguarding …

  • G1/24: Beyond the EPO 23 Oct 2025 23:04 GMT

    Shutterstock/Pand P Studio Following the landmark ruling on claim interpretation, Finnegan experts compare approaches across the IP5 and the UPC and show how these insights can strengthen globally robust patent drafting Register for limited access …

  • More collaboration on patents with the rest of the world than within Europe, study finds 23 Oct 2025 09:41 GMT

    … continent, an analysis by the European Patent Office (EPO) has revealed. The findings, released … launching the analysis.  The EPO tracked patents with more than one applicant … and transformation at the EPO Observatory on Patents and Technology, during the …

  • USPTO Hosts Trilateral Conference to Explore AI & IT Tech in Patent Examination 23 Oct 2025 01:14 GMT

    … with the European Patent Office and the Japan Patent Office at … IT systems can enhance patent examination efficiency and … the conference. Attendees included EPO vice president Steve Rowan, … . Participants reviewed current patent filing trends and shared …

  • Polymorph Patents 23 Oct 2025 00:53 GMT

    … itself, but strategies for patenting polymorphs of the compound. … , and stability. Therefore, patenting polymorphs can potentially add value … obtain a patent on a polymorph in the EPO. In … and Europe, filing polymorph patents in Europe should proceed …

Satisfied with the content?

Continue to create your account.